Delivery Order SPE2DB20D2014-SPE2DB24FB02T
- Not listed
- This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension 7.5mL to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $1,634.12, is a firm-fixed price delivery order with a completion date of December 19, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,548.79 fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of June 28, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for medical supplies and pharmaceutical products provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to the Defense Logistics Agency (DLA). The $2,145.60 delivery order (SPE2DB20D3101|SPE2DB24FRAJ8) is for Ciproflox-Dexameth Otic Suspension 7.5mL, with a completion date of February 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,320.95 fixed-price delivery order is for the pharmaceutical product Ciproflox-Dexameth Otic Suspension 7.5 mL and has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $11,824.35, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order with a firm fixed price pricing type, and the ultimate completion date is August 27, 2024. The contract is not designated as a set-aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,005.20 firm fixed-price delivery order is for the medical product "CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML" and has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,095.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,321.30 Firm Fixed Price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $1,348.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension, a specialized pharmaceutical product, with a completion date of July 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,535.14 firm fixed-price delivery order is for the supply of the medication Ciproflox-Dexameth Otic Suspension, with a period of performance through August 7, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB02TDelivery Order
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 mL) to the Defense Logistics Agency (DLA). The $3,215.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable the efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 2/7/24 |